Clinical Pharmacist - Investigational Drug Service Salary


What is the salary of a Clinical Pharmacist - Investigational Drug Service? In the United States, a Clinical Pharmacist - Investigational Drug Service earns an average salary of $168,909. The salary range for a Clinical Pharmacist - Investigational Drug Service is usually between $139,714 and $171,889 per year, representing the 25th to 75th percentiles respectively. The top 10% of earners, that is the 90th percentile, have an annual salary of $179,075. The highest Clinical Pharmacist - Investigational Drug Service salary in the United States was $179,075. The average hourly pay for a Clinical Pharmacist - Investigational Drug Service is $81.21.

Employer paying the highest salary for a Clinical Pharmacist - Investigational Drug Service job is Roswell Park Cancer Institute Corporation (NY).

Average Salary
$168,909/yr
Records Number
8
Employers Number
1
Job Pay Rank
5,218th

Clinical Pharmacist - Investigational Drug Service Salary Statistics


Advertisement

Top Paying Employers for Clinical Pharmacist - Investigational Drug Service Jobs

EmployerAverage Salary
Roswell Park Cancer Institute Corporation, NY$162,577

Top Paid Clinical Pharmacist - Investigational Drug Service

NameStateEmployer
Sam Milazzo M
Roswell Park Cancer Institute Corporation, NY
Sam Milazzo MNYRoswell Park Cancer Institute CorporationView Details
Lynne Guise M
Roswell Park Cancer Institute Corporation, NY
Lynne Guise MNYRoswell Park Cancer Institute CorporationView Details
Lynne Guise
Roswell Park Cancer Institute Corporation, NY
Lynne Guise NYRoswell Park Cancer Institute CorporationView Details
Lynne Guise M
Roswell Park Cancer Institute Corporation, NY
Lynne Guise MNYRoswell Park Cancer Institute CorporationView Details
John Pietkiewicz
Roswell Park Cancer Institute Corporation, NY
John Pietkiewicz NYRoswell Park Cancer Institute CorporationView Details
Denise Wellsjohnson M
Roswell Park Cancer Institute Corporation, NY
Denise Wellsjohnson MNYRoswell Park Cancer Institute CorporationView Details
Sam Milazzo
Roswell Park Cancer Institute Corporation, NY
Sam Milazzo NYRoswell Park Cancer Institute CorporationView Details
John Pietkiewicz M
Roswell Park Cancer Institute Corporation, NY
John Pietkiewicz MNYRoswell Park Cancer Institute CorporationView Details
Michael Spino J
Roswell Park Cancer Institute Corporation, NY
Michael Spino JNYRoswell Park Cancer Institute CorporationView Details
Kathy Galus
Roswell Park Cancer Institute Corporation, NY
Kathy Galus NYRoswell Park Cancer Institute CorporationView Details
Denise Wellsjohnson
Roswell Park Cancer Institute Corporation, NY
Denise Wellsjohnson NYRoswell Park Cancer Institute CorporationView Details
Michael Spino
Roswell Park Cancer Institute Corporation, NY
Michael Spino NYRoswell Park Cancer Institute CorporationView Details
Denise Wells-Johnson M
Roswell Park Cancer Institute Corporation, NY
Denise Wells-Johnson MNYRoswell Park Cancer Institute CorporationView Details
Linda Wickes
Roswell Park Cancer Institute Corporation, NY
Linda Wickes NYRoswell Park Cancer Institute CorporationView Details
Sam Milazzo M
Roswell Park Cancer Institute Corporation, NY
Sam Milazzo MNYRoswell Park Cancer Institute CorporationView Details
John Pietkiewicz M
Roswell Park Cancer Institute Corporation, NY
John Pietkiewicz MNYRoswell Park Cancer Institute CorporationView Details
Michael Spino J
Roswell Park Cancer Institute Corporation, NY
Michael Spino JNYRoswell Park Cancer Institute CorporationView Details
Linda Wickes J
Roswell Park Cancer Institute Corporation, NY
Linda Wickes JNYRoswell Park Cancer Institute CorporationView Details
Kathy Galus
Roswell Park Cancer Institute Corporation, NY
Kathy Galus NYRoswell Park Cancer Institute CorporationView Details
Sam Milazzo
Roswell Park Cancer Institute Corporation, NY
Sam Milazzo NYRoswell Park Cancer Institute CorporationView Details
Advertisement